Suministro de medicamentos exclusivos con principios activos Bexaroteno,Eribulina,Lenvatinib,Ribociclib,Erenumab,Midostaurina,Encorafenib,Binimetinib,Reslizumab y Fremanezumab.

Contract type	Supplies
CPV	33600000
Awarded to	EISAI FARMACEUTICA, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.